A pharmaceutical company that whistleblowers alleged paid doctors to prescribe its main drug and urged salespeople to push it as a way to control unruly dementia patients will pay more than $100 million to settle government fraud allegations.
from CNN.com - RSS Channel - App International Edition https://ift.tt/2logTsS
Post Top Ad
Thursday, September 26, 2019
Home
CNN.com - RSS Channel - App International Edition
Top Stories
Cashing in on dementia patients: drugmaker to pay $116 million in fraud settlement
Cashing in on dementia patients: drugmaker to pay $116 million in fraud settlement
Tags
# CNN.com - RSS Channel - App International Edition
# Top Stories
Share This
About hatim sama
Top Stories
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment